Skip to main content
Top
Published in: BMC Neurology 1/2022

Open Access 01-12-2022 | Magnetic Resonance Imaging | Case report

Advanced MRI features of intraventricular inflammatory myofibroblastic tumor: a case report

Authors: Xiao-lin Tang, Wen-jun Huang, Qiang Ma, Kun-ming Yi

Published in: BMC Neurology | Issue 1/2022

Login to get access

Abstract

Background

Inflammatory myofibroblastic tumor (IMT) is a rare central nervous system (CNS) tumor. We first report a rare case of IMT in the lateral ventricle and describe the magnetic resonance imaging (MRI) findings of the tumor with an emphasis on the advanced MRI features.

Case presentation

A 49-year-old female patient with headaches and blurred vision for 2 months. Brain MRI revealed a well-circumscribed, lobulated mass occupying the left lateral ventricle trigone, with marked perilesional brain edema. The tumor showed heterogeneous significant hyperintensity on T2-weighted imaging (T2WI) and hypointensity on T1-weighted imaging (T1WI). After the administration of gadolinium, the mass exhibited marked contrast enhancement and the halo sign was observed. On advanced MRI, the lesion showed decreased perfusion on perfusion MRI and reduced diffusion on diffusion-weighted imaging (DWI). On susceptibility-weighted imaging (SWI), there was a punctate low signal intensity in the tumor. The patient underwent surgical resection of the mass and a pathological examination confirmed the lesion to be an inflammatory myofibroblastic tumor with negative expression of anaplastic lymphoma kinase (ALK). This patient had remained healthy without evidence of recurrence during a 20-month follow-up.

Conclusions

On MRI, marked perilesional brain edema, significant hyperintensity on T2WI, hypoperfusion on perfusion MRI but with an obvious enhancement, no diffusion restriction on DWI, and halo sign may be the characteristic findings of intraventricular IMT. The advanced MRI characteristics could provide abundant information to reflect the histological features and physiological metabolic characteristics of the tumor.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fletcher CD, Unni KK, Mertens F. World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon: IARC Press; 2002. Fletcher CD, Unni KK, Mertens F. World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon: IARC Press; 2002.
2.
go back to reference Swain RS, Tihan T, Horvai AE, et al. Inflammatory myofibroblastic tumor of the central nervous system and its relationship to inflammatory pseudotumor. Hum Pathol. 2008;39:410–9.CrossRefPubMed Swain RS, Tihan T, Horvai AE, et al. Inflammatory myofibroblastic tumor of the central nervous system and its relationship to inflammatory pseudotumor. Hum Pathol. 2008;39:410–9.CrossRefPubMed
3.
go back to reference Wang X, Chen Y, Wu X, Zhang H. Intracranial inflammatory myofibroblastic tumor with negative expression of anaplastic lymphoma kinase: a case report and review of the literature. World Neurosurg. 2019;125:117–22.CrossRefPubMed Wang X, Chen Y, Wu X, Zhang H. Intracranial inflammatory myofibroblastic tumor with negative expression of anaplastic lymphoma kinase: a case report and review of the literature. World Neurosurg. 2019;125:117–22.CrossRefPubMed
4.
go back to reference Häusler M, Schaade L, Ramaekers VT, Doenges M, Heimann G, Sellhaus B. Inflammatory pseudotumors of the central nervous system: Report of 3 cases and a literature review. Hum Pathol. 2003;34(3):253–62.CrossRefPubMed Häusler M, Schaade L, Ramaekers VT, Doenges M, Heimann G, Sellhaus B. Inflammatory pseudotumors of the central nervous system: Report of 3 cases and a literature review. Hum Pathol. 2003;34(3):253–62.CrossRefPubMed
6.
go back to reference Phogat D, Datta S, Bajpai M, Tara S, Ganti SK. Intracranial inflammatory myofibroblastic tumor: a review of 49 cases. Autops Case Rep. 2021;11:e2021254.CrossRefPubMedPubMedCentral Phogat D, Datta S, Bajpai M, Tara S, Ganti SK. Intracranial inflammatory myofibroblastic tumor: a review of 49 cases. Autops Case Rep. 2021;11:e2021254.CrossRefPubMedPubMedCentral
7.
go back to reference Kato K, Moteki Y, Nakagawa M, Kadoyama S, Ujiie H. Inflammatory myofibroblastic tumor of the cerebellar hemisphere--case report. Neurol Med Chir (Tokyo). 2011;51(1):79–81.CrossRefPubMed Kato K, Moteki Y, Nakagawa M, Kadoyama S, Ujiie H. Inflammatory myofibroblastic tumor of the cerebellar hemisphere--case report. Neurol Med Chir (Tokyo). 2011;51(1):79–81.CrossRefPubMed
8.
go back to reference Maire JP, Eimer S, San GF, et al. Inflammatory myofibroblastic tumour of the skull base. Case Rep Otolaryngol. 2013;2013:1–5.CrossRef Maire JP, Eimer S, San GF, et al. Inflammatory myofibroblastic tumour of the skull base. Case Rep Otolaryngol. 2013;2013:1–5.CrossRef
9.
go back to reference Thavara BD, Rajagopalawarrier B, Ramaswamy JC, Kidangan GS. Central nervous system inflammatory myofibroblastic tumor presenting as a scalp abscess. Neurol India. 2020;68(3):703–5.CrossRefPubMed Thavara BD, Rajagopalawarrier B, Ramaswamy JC, Kidangan GS. Central nervous system inflammatory myofibroblastic tumor presenting as a scalp abscess. Neurol India. 2020;68(3):703–5.CrossRefPubMed
10.
go back to reference Messina C, Bignone R, Bruno A, et al. Diffusion-weighted imaging in oncology: an update. Cancers. 2020;12(6):2–26.CrossRef Messina C, Bignone R, Bruno A, et al. Diffusion-weighted imaging in oncology: an update. Cancers. 2020;12(6):2–26.CrossRef
11.
go back to reference Aker L, Abandeh L, Abdelhady M, Aboughalia H, Vattoth S. Susceptibility-weighted imaging in neuroradiology: practical imaging principles, pearls and pitfalls. Curr Probl Diagn Radiol. 2021;7(8):91–8. Aker L, Abandeh L, Abdelhady M, Aboughalia H, Vattoth S. Susceptibility-weighted imaging in neuroradiology: practical imaging principles, pearls and pitfalls. Curr Probl Diagn Radiol. 2021;7(8):91–8.
12.
go back to reference Fayed N, Modrego PJ. The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours. J Neuro-Oncol. 2005;72(3):261–5.CrossRef Fayed N, Modrego PJ. The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours. J Neuro-Oncol. 2005;72(3):261–5.CrossRef
13.
go back to reference Le Bas JF, Grand S, Krainik A, Lefournier V, Tropres I, Rémy C. Perfusion MR imaging in brain tumors. J Radiol. 2006;87(6 Pt 2):807–21.PubMed Le Bas JF, Grand S, Krainik A, Lefournier V, Tropres I, Rémy C. Perfusion MR imaging in brain tumors. J Radiol. 2006;87(6 Pt 2):807–21.PubMed
Metadata
Title
Advanced MRI features of intraventricular inflammatory myofibroblastic tumor: a case report
Authors
Xiao-lin Tang
Wen-jun Huang
Qiang Ma
Kun-ming Yi
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02993-8

Other articles of this Issue 1/2022

BMC Neurology 1/2022 Go to the issue